
Mysteries of Microphthalmia, Isolated, with Coloboma 10: Unraveling the Genetic Threads
Explore how genetic testing aids in diagnosing microphthalmia with coloboma 10. Uncover genetic insights, counseling guidance, and early intervention benefits.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore how genetic testing aids in diagnosing microphthalmia with coloboma 10. Uncover genetic insights, counseling guidance, and early intervention benefits.

Explore the role of genetic testing in diagnosing rare mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, enhancing treatment and family planning options.

Explore the impact of genetic testing on Multiple Mitochondrial Dysfunctions Syndrome 4, aiding early diagnosis, personalized treatment, and informed family planning.

Unlock the complexities of Muscular Dystrophy-Dystroglycanopathy Type A9. Explore genetic testing's role in diagnosis, early intervention, and genetic counseling.

Explore how genetic testing can improve diagnosis and treatment of myoclonic-atonic epilepsy, enhancing precision medicine for this rare childhood epilepsy syndrome.

Explore Myoclonic Dystonia 26's genetic insights, diagnosis, and personalized treatment through genetic testing, enhancing outcomes for patients and their families.

Explore how genetic testing transforms NECRDS management by identifying predispositions, informing care, predicting progression, and paving the way for personalized medicine.

Explore how genetic testing enhances the diagnosis of Hereditary Motor and Sensory Neuropathy Type 6B, aiding in early intervention and informed family planning.